Literature DB >> 34271873

LncRNA MCM3AP-AS1 sponges miR-148a to enhance cell invasion and migration in small cell lung cancer.

Hua Luo1, Yukun Zhang2, Guangmei Qin1, Bing Jiang1, Lili Miao1.   

Abstract

BACKGROUND: MCM3AP-AS1 is a recently characterized lncRNA playing an oncogenic role in several cancers. However, its role in lung cancer remains unknown. Here, we aimed to explore the functions of MCM3AP-AS1 in small cell lung cancer (SCLC) and the possible underlying mechanisms.
METHODS: MCM3AP-AS1 and ROCK1 levels in SCLC patients were analyzed by qPCR. RNA pull-down and luciferase assays were performed to analyze the interaction between MCM3AP-AS1 and miR-148a. ROCK1 mRNA and protein levels were detected by qPCR and Western blot, respectively. Cell invasion and migration were analyzed by Transwell assays.
RESULTS: MCM3AP-AS1 was upregulated in patients with SCLC, and a high MCM3AP-AS1 level was accompanied by a low survival rate. The binding of MCM3AP-AS1 to miR-148a predicted by bioinformatics analysis was verified by RNA pull-down and luciferase assays. However, MCM3AP-AS1 and miR-148a did not affect each other's expression. ROCK1 was upregulated in SCLC tissues and positively correlated with MCM3AP-AS1. In SCLC cells, MCM3AP-AS1 overexpression increased ROCK1 and promoted cancer cell invasion and migration, while miR-148a overexpression showed the opposite effects and attenuated the effects of MCM3AP-AS1 overexpression on ROCK1 expression and cell behaviors.
CONCLUSIONS: MCM3AP-AS1 sponges miR-148a, thereby increasing SCLC cell invasion and migration via upregulating ROCK1 expression.
© 2021. The Author(s).

Entities:  

Keywords:  MCM3AP-AS1; ROCK1; Small cell lung cancer; Survival; miR-148a

Year:  2021        PMID: 34271873     DOI: 10.1186/s12885-021-08365-8

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  20 in total

1.  The lncRNA MIR4435-2HG promotes lung cancer progression by activating β-catenin signalling.

Authors:  Haiyun Qian; Li Chen; Jiangping Huang; Xianghui Wang; Shengwei Ma; Fenghe Cui; Liyun Luo; Li Ling; Kai Luo; Guopei Zheng
Journal:  J Mol Med (Berl)       Date:  2018-06-05       Impact factor: 4.599

2.  YY1-mediated overexpression of long noncoding RNA MCM3AP-AS1 accelerates angiogenesis and progression in lung cancer by targeting miR-340-5p/KPNA4 axis.

Authors:  Xuemei Li; Mei Yu; Caiyong Yang
Journal:  J Cell Biochem       Date:  2019-11-06       Impact factor: 4.429

3.  Comprehensive genomic profiles of small cell lung cancer.

Authors:  Julie George; Jing Shan Lim; Se Jin Jang; Yupeng Cun; Luka Ozretić; Gu Kong; Frauke Leenders; Xin Lu; Lynnette Fernández-Cuesta; Graziella Bosco; Christian Müller; Ilona Dahmen; Nadine S Jahchan; Kwon-Sik Park; Dian Yang; Anthony N Karnezis; Dedeepya Vaka; Angela Torres; Maia Segura Wang; Jan O Korbel; Roopika Menon; Sung-Min Chun; Deokhoon Kim; Matt Wilkerson; Neil Hayes; David Engelmann; Brigitte Pützer; Marc Bos; Sebastian Michels; Ignacija Vlasic; Danila Seidel; Berit Pinther; Philipp Schaub; Christian Becker; Janine Altmüller; Jun Yokota; Takashi Kohno; Reika Iwakawa; Koji Tsuta; Masayuki Noguchi; Thomas Muley; Hans Hoffmann; Philipp A Schnabel; Iver Petersen; Yuan Chen; Alex Soltermann; Verena Tischler; Chang-min Choi; Yong-Hee Kim; Pierre P Massion; Yong Zou; Dragana Jovanovic; Milica Kontic; Gavin M Wright; Prudence A Russell; Benjamin Solomon; Ina Koch; Michael Lindner; Lucia A Muscarella; Annamaria la Torre; John K Field; Marko Jakopovic; Jelena Knezevic; Esmeralda Castaños-Vélez; Luca Roz; Ugo Pastorino; Odd-Terje Brustugun; Marius Lund-Iversen; Erik Thunnissen; Jens Köhler; Martin Schuler; Johan Botling; Martin Sandelin; Montserrat Sanchez-Cespedes; Helga B Salvesen; Viktor Achter; Ulrich Lang; Magdalena Bogus; Peter M Schneider; Thomas Zander; Sascha Ansén; Michael Hallek; Jürgen Wolf; Martin Vingron; Yasushi Yatabe; William D Travis; Peter Nürnberg; Christian Reinhardt; Sven Perner; Lukas Heukamp; Reinhard Büttner; Stefan A Haas; Elisabeth Brambilla; Martin Peifer; Julien Sage; Roman K Thomas
Journal:  Nature       Date:  2015-07-13       Impact factor: 49.962

Review 4.  Global trends of lung cancer mortality and smoking prevalence.

Authors:  Farhad Islami; Lindsey A Torre; Ahmedin Jemal
Journal:  Transl Lung Cancer Res       Date:  2015-08

Review 5.  Small cell lung cancer (SCLC): no treatment advances in recent years.

Authors:  Filippos Koinis; Athanasios Kotsakis; Vasileios Georgoulias
Journal:  Transl Lung Cancer Res       Date:  2016-02

Review 6.  Lung cancer in never smokers--a different disease.

Authors:  Sophie Sun; Joan H Schiller; Adi F Gazdar
Journal:  Nat Rev Cancer       Date:  2007-10       Impact factor: 60.716

Review 7.  Origins, genetic landscape, and emerging therapies of small cell lung cancer.

Authors:  Ekaterina A Semenova; Remco Nagel; Anton Berns
Journal:  Genes Dev       Date:  2015-07-15       Impact factor: 11.361

8.  A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.

Authors:  Yufeng Wang; Liu Yang; Tianxiang Chen; Xin Liu; Yang Guo; Qiaojuan Zhu; Xiangmin Tong; Wei Yang; Qiuran Xu; Dongsheng Huang; Kangsheng Tu
Journal:  Mol Cancer       Date:  2019-02-19       Impact factor: 27.401

Review 9.  Long non-coding RNA: a new player in cancer.

Authors:  Hua Zhang; Zhenhua Chen; Xinxin Wang; Zunnan Huang; Zhiwei He; Yueqin Chen
Journal:  J Hematol Oncol       Date:  2013-05-31       Impact factor: 17.388

10.  The Effect of MCM3AP-AS1/miR-211/KLF5/AGGF1 Axis Regulating Glioblastoma Angiogenesis.

Authors:  Chunqing Yang; Jian Zheng; Yixue Xue; Hai Yu; Xiaobai Liu; Jun Ma; Libo Liu; Ping Wang; Zhen Li; Heng Cai; Yunhui Liu
Journal:  Front Mol Neurosci       Date:  2018-01-09       Impact factor: 5.639

View more
  7 in total

Review 1.  A review on the role of MCM3AP-AS1 in the carcinogenesis and tumor progression.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Mohammad Taheri; Mohammad Samadian
Journal:  Cancer Cell Int       Date:  2022-07-05       Impact factor: 6.429

2.  Identification of key genes and pathway related to chemoresistance of small cell lung cancer through an integrative bioinformatics analysis.

Authors:  Fan-Rui Zeng; Xu-Yang Zhou; Ling-Ge Zeng; Jian-Cong Sun; Fen He; Wei Mo; Yang Wen; Shu-Yu Wang; Qin Liu; Lin-Lang Guo
Journal:  Ann Transl Med       Date:  2022-09

3.  Over-Expression of Long Non-Coding RNA-AC099850.3 Correlates With Tumor Progression and Poor Prognosis in Lung Adenocarcinoma.

Authors:  Xi Chen; Jishu Guo; Fan Zhou; Wenjun Ren; Jun Pu; Luciano Mutti; Xiaoqun Niu; Xiulin Jiang
Journal:  Front Oncol       Date:  2022-05-11       Impact factor: 5.738

4.  LncRNA SNHG20 promotes migration and invasion of ovarian cancer via modulating the microRNA-148a/ROCK1 axis.

Authors:  Qi Yang; Yu-Jie Dong
Journal:  J Ovarian Res       Date:  2021-11-26       Impact factor: 4.234

5.  The Prognostic Value of lncRNA MCM3AP-AS1 on Clinical Outcomes in Various Cancers: A Meta- and Bioinformatics Analysis.

Authors:  Liangyin Fu; Guangming Zhang; Yongfeng Wang; Tingting Lu; Bin Liu; Yajun Jiao; Haizhong Ma; Shixun Ma; Kehu Yang; Hui Cai
Journal:  Dis Markers       Date:  2022-06-24       Impact factor: 3.464

Review 6.  Implication of non-coding RNA-mediated ROCK1 regulation in various diseases.

Authors:  Soudeh Ghafouri-Fard; Yadollah Poornajaf; Bashdar Mahmud Hussen; Atefe Abak; Hamed Shoorei; Mohammad Taheri; Guive Sharifi
Journal:  Front Mol Biosci       Date:  2022-09-13

7.  Significance of long non-coding RNA IFNG-AS1 in the progression and clinical prognosis in colon adenocarcinoma.

Authors:  Zhaoshun Wang; Zhongzheng Cao; Zhen Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.